BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ

$52.13

-$1.18 (2.21%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$50.90$53.57

Open $53.34

52 Week Range

$50.76$73.51

Previous Close $53.31

Market Cap10.01B

Volume2.18M

Avg Volume2.69M

P/E (TTM)19.24

EPS (TTM)$2.71

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for BioMarin Pharmaceutical Inc.

NOV112025

BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

Source: PRNewsWire•34 days ago

SAN RAFAEL, Calif. , Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, Englan...

OCT292025

FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

Source: PRNewsWire•47 days ago

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet alone FDA PDUFA target action date of Feb. 28, 2026 SAN RAFAEL, Calif. , Oct. 29, 2025 ...

OCT272025

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

Source: PRNewsWire•49 days ago

Raises Full-year 2025 Total Revenues Guidance at the Midpoint; Reaffirms VOXZOGO Full-year Outlook 2025 Year-to-date Total Revenues Increased 11% Y/Y Led by More Than 20% Revenue Growth for PALYNZIQ and VOXZOGO BioMarin Focuses Commercial Portfolio; ...

OCT222025

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

Source: PRNewsWire•54 days ago

SAN RAFAEL, Calif. , Oct. 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, October 27, 202...